PLIOBOND

Potential health effects

EYE: CAN CAUSE EYE IRRITATION. SYMPTOMS INCLUDE STINGING, TEARING, REDNESS, AND SWELLING OF EYES. SKIN: CAN CAUSE SKIN IRRITATION. PROLONGED OR REPEATED CONTACT MAY DRY THE SKIN. SYMPTOMS MAY INCLUDE REDNESS, BURNING, AND DRYING AND CRACKING OF SKIN, BURNS AND OTHER SKIN DAMAGE. ADDITIONAL SYMPTOMS OF SKIN CONTACT MAY INCLUDE: ALLERGIC SKIN REACTION (DELAYED SKIN RASH WHICH MAY BE FOLLOWED BY BLISTERING, SCALING AND OTHER SKIN EFFECTS). SWALLOWING: SWALLOWING SMALL AMOUNTS OF THIS MATERIAL DURING NORMAL HANDLING IS NOT LIKELY TO CAUSE HARMFUL EFFECTS. SWALLOWING LARGE AMOUNTS MAY BE HARMFUL. THIS MATERIAL CAN GET INTO THE LUNGS DURING SWALLOWING OR VOMITING. THIS RESULTS IN LUNG INFLAMMATION AND OTHER LUNG INJURY. INHALATION: BREATHING OF VAPOR OR MIST IS POSSIBLE. BREATHING SMALL AMOUNTS OF THIS MATERIAL DURING NORMAL HANDLING IS NOT LIKELY TO CAUSE HARMFUL EFFECTS. BREATHING LARGE AMOUNTS MAY BE HARMFUL. SYMPTOMS USUALLY OCCUR AT AIR CONCENTRATIONS HIGHER THAN THE RECOMMENDED EXPOSURE LIMITS (SEE SECTION 8). SYMPTOMS OF EXPOSURE: SIGNS AND SYMPTOMS OF EXPOSURE TO THIS MATERIAL THROUGH BREATHING, SWALLOWING, AND/OR PASSAGE Of THE MATERIAL THROUGH THE SKIN MAY INCLUDE: STOMACH OR INTESTINAL UPSET (NAUSEA, VOMITING, DIARRHEA) IRRITATION (NOSE, THROAT, AIRWAYS), CENTRAL NERVOUS SYSTEM DEPRESSION (DIZZINESS, DROWSINESS, WEAKNESS, FATIGUE, NAUSEA, HEADACHE, UNCONSCIOUSNESS) . TARGET ORGAN EFFECTS: BASED ON ANIMAL STUDIES, EXPOSURE TO METHYL ETHYL KETONE (MEK) INCREASES THE ONSET OF PERIPHERAL NEUROPATHY CAUSED BY EXPOSURE TO METHYL BUTYL KETONE (MBK), AND/OR n-HEXANE, AND/OR ETHYL BUTYL KETONE. MEK ALONE HAS NOT BEEN SHOWN TO CAUSE PERIPHERAL NEUROPATHY. @ OVEREXPOSURE TO THIS MATERIAL (OR ITS COMPONENTS) HAS BEEN SUGGESTED AS A CAUSE OF THE FOLLOWING EFFECTS IN LABORATORY ANIMALS: MILD, REVERSIBLE LIVER EFFECTS, MILD, REVERSIBLE KIDNEY EFFECTS. | https://www.dolphinrtk.com/msds/PrintMSDS_HTML.asp __ . _ a __giteinnnn *PLIOBOND 20 Page 3 of 8 “ DEVELOPMENTAL INFORMATION: THIS MATERIAL (OR A COMPONENT). HAS BEEN SHOWN TO CAUSE HARM TO THE FETUS IN LABORATORY ANIMAL STUDIES. THE RELEVANCE OF THESE FINDINGS TO HUMANS IS UNCERTAIN.

Cancer information

HUMAN STUDIES HAVE ASSOCIATED NASOPHARYNGEAL CANCERS (AREA OF THE UPPER THROAT BEHIND THE NOSE) AND POSSIBLY OTHER RESPIRATORY CANCERS (NASAL CAVITY AND SINUSES) WITH FORMALDEHYDE EXPOSURE IN THE WORKPLACE. ALTHOUGH THE EVIDENCE IS NOT CONCLUSIVE, SOME STUDIES SUGGEST AN ASSOCIATION BETWEEN WORKPLACE FORMALDEHYDE EXPOSURE AND LEUKEMIA. IN STUDIES IN RATS, INHALATION OF FORMALDEHYDE HAS CAUSED NASAL TUMORS, WHILE INGESTION IN DRINKING WATER HAS CAUSED LEUKEMIA AND GASTROINTESTINAL TRACT TUMORS. FORMALDEHYDE IS LISTED AS A CARCINOGEN BY THE INTERNATIONAL AGENCY FOR RESEARCH ON CANCER (IARC), THE NATIONAL TOXICOLOGY PROGRAM (NTP) AND THE OCCUPATIONAL SAFETY AND HEALTH ADMINISTRATION

Other Health Effects

NO DATA PRIMARY ROUTE(S) OF ENTRY: INHALATION, SKIN CONTACT, EYE CONTACT, INGESTION.